Over half a million individuals get HIV care from HRSA's Ryan White HIV/AIDS Program (RWHAP), of which 1.9% are transgender. The majority of RWHAP transgender clients are from racial/ethnic minority populations facing a range of challenges, from limited resources to unstable housing.
In 2018, among RWHAP transgender clients receiving HIV medical care, 81.8% were virally suppressed, compared to the national RWHAP average of 87.1%. As the graph shows, viral suppression rates lag for specific RWHAP transgender populations. However, viral suppression rates for all RWHAP populations have improved remarkably, going from 69.5% to 87.1% over the time period 2010-2018 (2018 RWHAP Annual Client-Level Data Report, HRSA 2019).
Learn about Ending the HIV Epidemic: A Plan for America, which seeks to end the HIV epidemic in the United States within 10 years
Learn more: See the fact sheet Transgender Clients: Ryan White HIV/AIDS Program, 2018 (HRSA, January 2020)
HRSA Transgender Resources
HRSA's HIV/AIDS Bureau (HAB) has multiple initiatives and resources to support transgender individuals living with HIV. See our Transgender People topic page, featuring the following:
SPNS Innovations in Care for Transgender Women of Color
The SPNS initiative, Enhancing Engagement and Retention in Quality HIV Care for Transgender Women of Color Initiative (2012-2017) produced a series of Intervention Manuals with innovative interventions to improve timely entry, engagement and retention in quality HIV care.
Clinical Quality Management
The end+disparities ECHO Collaborative is a HRSA-supported national improvement initiative. Its goal is to measurably increase viral suppression rates for four disproportionately affected RWHAP subpopulations: transgender people; African American women, Latinas, MSM of color, and youth. See the five-part ECHO Didactic Presentations on transgender people.
The National HIV Curriculum includes a training module covering HIV among sexual and gender minorities. Health care professionals may receive continuing education credits for completion of the segment. Topics include epidemiology, HIV risks, barriers to care, and successful care approaches. See also the HHS Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, which added a new section, Transgender People with HIV, in December 2019.